These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21703735)

  • 1. Potentially increasing the metabolic stability of drug candidates via computational site of metabolism prediction by CYP2C9: The utility of incorporating protein flexibility via an ensemble of structures.
    Danielson ML; Desai PV; Mohutsky MA; Wrighton SA; Lill MA
    Eur J Med Chem; 2011 Sep; 46(9):3953-63. PubMed ID: 21703735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD).
    Lokwani DK; Sarkate AP; Karnik KS; Nikalje APG; Seijas JA
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining structure- and ligand-based approaches to improve site of metabolism prediction in CYP2C9 substrates.
    Kingsley LJ; Wilson GL; Essex ME; Lill MA
    Pharm Res; 2015 Mar; 32(3):986-1001. PubMed ID: 25208877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site of metabolism prediction on cytochrome P450 2C9: a knowledge-based docking approach.
    Tarcsay A; Kiss R; Keseru GM
    J Comput Aided Mol Des; 2010 May; 24(5):399-408. PubMed ID: 20361237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of metabolism by cytochrome P450 2C9: alignment and docking studies of a validated database of substrates.
    Sykes MJ; McKinnon RA; Miners JO
    J Med Chem; 2008 Feb; 51(4):780-91. PubMed ID: 18237107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DR-predictor: incorporating flexible docking with specialized electronic reactivity and machine learning techniques to predict CYP-mediated sites of metabolism.
    Huang TW; Zaretzki J; Bergeron C; Bennett KP; Breneman CM
    J Chem Inf Model; 2013 Dec; 53(12):3352-66. PubMed ID: 24261543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling used to evaluate CYP2C9-dependent metabolism: homology modeling, molecular dynamics and docking simulations.
    Mendieta-Wejebe JE; Correa-Basurto J; García-Segovia EM; Ceballos-Cancino G; Rosales-Hernández MC
    Curr Drug Metab; 2011 Jul; 12(6):533-48. PubMed ID: 21486213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of CYP2C9 Structural Models for Site of Metabolism Prediction.
    Zhang X; Xu M; Wu Z; Liu G; Tang Y; Li W
    ChemMedChem; 2021 Jun; 16(11):1754-1763. PubMed ID: 33600055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.
    Zhou SF; Zhou ZW; Yang LP; Cai JP
    Curr Med Chem; 2009; 16(27):3480-675. PubMed ID: 19515014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based site of metabolism prediction for cytochrome P450 2D6.
    Moors SL; Vos AM; Cummings MD; Van Vlijmen H; Ceulemans A
    J Med Chem; 2011 Sep; 54(17):6098-105. PubMed ID: 21797232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the binding of proton pump inhibitors to human P450 2C9 based on docking and molecular dynamics simulation.
    Shi R; Li J; Cao X; Zhu X; Lu X
    J Mol Model; 2011 Aug; 17(8):1941-51. PubMed ID: 21120554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I.
    Mo SL; Zhou ZW; Yang LP; Wei MQ; Zhou SF
    Curr Drug Metab; 2009 Dec; 10(10):1075-126. PubMed ID: 20167001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part II.
    Mo SL; Zhou ZW; Yang LP; Wei MQ; Zhou SF
    Curr Drug Metab; 2009 Dec; 10(10):1127-50. PubMed ID: 20167000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolism in cytochrome P450 2C9.
    Lonsdale R; Houghton KT; Żurek J; Bathelt CM; Foloppe N; de Groot MJ; Harvey JN; Mulholland AJ
    J Am Chem Soc; 2013 May; 135(21):8001-15. PubMed ID: 23641937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C9 structure-metabolism relationships: substrates, inhibitors, and metabolites.
    Ahlström MM; Ridderström M; Zamora I
    J Med Chem; 2007 Nov; 50(22):5382-91. PubMed ID: 17915853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of cytochrome P450 xenobiotic metabolism: tethered docking and reactivity derived from ligand molecular orbital analysis.
    Tyzack JD; Williamson MJ; Torella R; Glen RC
    J Chem Inf Model; 2013 Jun; 53(6):1294-305. PubMed ID: 23701380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4.
    Yuki H; Honma T; Hata M; Hoshino T
    Bioorg Med Chem; 2012 Jan; 20(2):775-83. PubMed ID: 22197672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, and substrate metabolism of gold-immobilized cytochrome P450 2C9.
    Gannett PM; Kabulski J; Perez FA; Liu Z; Lederman D; Locuson CW; Ayscue RR; Thomsen NM; Tracy TS
    J Am Chem Soc; 2006 Jul; 128(26):8374-5. PubMed ID: 16802783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of protein flexibility on the site of metabolism prediction for CYP2A6 substrates.
    Sheng Y; Chen Y; Wang L; Liu G; Li W; Tang Y
    J Mol Graph Model; 2014 Nov; 54():90-9. PubMed ID: 25459760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of metabolic soft spot predictions of CYP3A4, CYP2C9 and CYP2D6 substrates using MetaSite and StarDrop.
    Shin YG; Le H; Khojasteh C; Hop CE
    Comb Chem High Throughput Screen; 2011 Nov; 14(9):811-23. PubMed ID: 21605066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.